Molecular profile
Molecular profile
- Molecule class
- Synthetic peptide
- Origin
- Synthetic analogue
- Primary target system
- Neurotrophin-, Melanocortin- und stressbezogene Signalwege
- Development stage
- Authorised active substance
Synthetisches ACTH-Fragmentanalogon ohne klassische adrenocorticotrope Vollaktivität.
Mechanism and signalling
Mechanism and signalling
Proposed mechanisms include neurotrophic factors, oxidative-stress responses and monoaminergic signalling. Activity is not reducible to one receptor.
Scientific classification
Scientific classification
This profile maps Semax to the research areas neuro. Molecule class, evidence level, development stage and regulatory status are separated so that preclinical findings are not confused with authorised uses.
Neuropeptides and analogues in models of neuronal signalling, stress and pain.
Evidence base
Clinical data
Some clinical literature comes from regional programmes and has limited international replication. There is no EU or U.S. authorisation.
Regulatory status
Status varies by region
Regulatory status differs by country, product form and intended use. Authorisation in one jurisdiction does not transfer to Germany or the EU.
Safety and use notice
No dosing or administration recommendation
The available evidence does not establish safe self-directed use. This profile intentionally provides no dosing, sourcing or administration guidance.
Sources and registries